The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders.
Cheen Euong AngQing MaOrly L WapinskiShengHua FanRyan A FlynnQian Yi LeeBradley CoeMasahiro OnoguchiVictor Hipolito OlmosBrian T DoLynn Dukes-RimskyJin XuKoji TanabeLiangJiang WangUlrich EllingJosef M PenningerYang ZhaoKun QuEvan E EichlerAnand SrivastavaMarius WernigHoward Y ChangPublished in: eLife (2019)
Long noncoding RNAs (lncRNAs) have been shown to act as important cell biological regulators including cell fate decisions but are often ignored in human genetics. Combining differential lncRNA expression during neuronal lineage induction with copy number variation morbidity maps of a cohort of children with autism spectrum disorder/intellectual disability versus healthy controls revealed focal genomic mutations affecting several lncRNA candidate loci. Here we find that a t(5:12) chromosomal translocation in a family manifesting neurodevelopmental symptoms disrupts specifically lnc-NR2F1. We further show that lnc-NR2F1 is an evolutionarily conserved lncRNA functionally enhances induced neuronal cell maturation and directly occupies and regulates transcription of neuronal genes including autism-associated genes. Thus, integrating human genetics and functional testing in neuronal lineage induction is a promising approach for discovering candidate lncRNAs involved in neurodevelopmental diseases.
Keyphrases
- copy number
- intellectual disability
- endothelial cells
- single cell
- genome wide
- cell fate
- mitochondrial dna
- long non coding rna
- autism spectrum disorder
- transcription factor
- induced pluripotent stem cells
- pluripotent stem cells
- high glucose
- poor prognosis
- long noncoding rna
- dna methylation
- genome wide identification
- cell therapy
- spinal cord injury
- mesenchymal stem cells
- gene expression
- genome wide analysis
- depressive symptoms
- bone marrow
- diabetic rats